Jisoo X. Jean

Jisoo X. Jean

Auto-generated profile, based on publicly available information

Jisoo X. Jean

Department of Biochemistry, University of Oxford , South Parks Road, Oxford, OX1 3QU, U.K.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CBCan M. Buldun
Can M. Buldun
JJJisoo X. Jean
Jisoo X. Jean
MBMichael R. Bedford
Michael R. Bedford
MHMark Howarth
Mark Howarth

21 April 2016 in Scientific Reports
Verified
Journal Article
Open access
JTJonathan D. Taylor
Jonathan D. Taylor
WHWilliam J. Hawthorne
William J. Hawthorne
JLJoanne Lo
Joanne Lo
ADAlexander John Dear
Alexander John Dear
NJNeha Jain
Neha Jain
SMSteve Matthews
Steve Matthews
Polypeptide aggregation into amyloid is linked with several debilitating human diseases. Despite the inherent risk of aggregation-induced cytotoxicity, bacteria control the export of amyloid-prone subunits and assemble adhesive amyloid fibres during biofilm formation. AnEscherichiaprotein, CsgC potently inhibits amyloid formation of curli amyloid proteins. Here we unlock its mechanism of action, and show that CsgC strongly inhibits primary nucleation via electrostatically-guided molecular encounters, which expands the conformational distribution of disordered curli subunits. This delays the formation of higher order intermediates and maintains amyloidogenic subunits in a secretion-competent form. New structural insight also reveal that CsgC is part of diverse family of bacterial amyloid inhibitors. Curli assembly is therefore not only arrested in the periplasm, but the preservation of conformational flexibility also enables efficient secretion to the cell surface. Understanding how bacteria safely handle amyloidogenic polypeptides contribute towards efforts to control aggregation in disease-causing amyloids and amyloid-based biotechnological applications.